Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1Phase 2 1

Status

Recruiting 12Unknown 10Completed 6Terminated 5Withdrawn 3Not yet recruiting 2

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 2Tumor-Agnostic 1

Conditions

Locally Advanced Pancreatic Cancer 1Carcinoma, Hepatocellular 1Adenocarcinoma 1

Interventions

Radiotherapy 91pembrolizumab 88Cyclophosphamide 84Gemcitabine 70Cisplatin 70Magnetic Resonance Spectroscopy 65Carboplatin 60Radiosurgery 55Paclitaxel 55Nivolumab 48Dexamethasone 45Bevacizumab 42Biopsy 41Fluorouracil 39durvalumab 37Surveys and Questionnaires 36Docetaxel 36fludarabine 35Doxorubicin 35Radiation 33Oxaliplatin 33Capecitabine 33Rituximab 32fludarabine phosphate 31Leucovorin 31Cytarabine 30Melphalan 29Etoposide 28Pemetrexed 27Irinotecan 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Withdrawn × OTHER × Heavy Ion Radiotherapy × Clear all
NCT03536182 2021-05-26

CIPHER

University of Texas Southwestern Medical Center

Phase 3 Withdrawn
Tumor-Agnostic

Adenocarcinoma

NCT02946138 2019-09-09

Phase II Trial of Carbon-ion Radiotherapy Combined With GM-CSF for the Treatment of Hepatocellular Carcinoma

Shanghai Proton and Heavy Ion Center

Phase 2 Withdrawn
Gastrointestinal

Carcinoma, Hepatocellular

NCT01795274 2018-05-17

PHOENIX-01

University Hospital Heidelberg

Phase NA Withdrawn
Gastrointestinal

Locally Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡